Over the past 30 years, the raccoon-associated roundworm *Baylisascaris procyonis* has emerged as an uncommon but noteworthy human pathogen associated with devastating eosinophilic meningoencephalitis in 25 patients ([@R1]--[@R4]). We report a case of neural larva migrans in an otherwise generally healthy man in California, USA.

Case Report
===========

On May 18, 2015, a 63-year-old man was hospitalized in Humboldt County, California, after 2 weeks of fatigue, memory impairment, and progressive confusion accompanied by right-sided occipital headache and right-sided allodynia involving his arm and head. He was confused and disoriented to date but could recognize family; engage in brief, logical conversations; and walk independently. His medical history included essential thrombocytosis, hypothyroidism, and a remote episode of shingles. Vital signs were normal; physical examination showed no focal abnormalities. His complete blood count showed a leukocyte count of 11.5 × 10^9^ cells/L (reference range 3.4--10 × 10^9^ cells/L), eosinophil count of 0.75 × 10^9^ cells/L (reference range \<0.4 × 10^9^ cells/L), and neutrophil count of 6.1 × 10^9^/L (reference range 1.8--6.8 × 10^9^ cells/L). Chemistry and liver panel results were normal. A brain magnetic resonance imaging (MRI) demonstrated no intracranial pathology. Cerebrospinal fluid (CSF) showed a leukocyte count of 183 × 10^9^ cells/L (60% lymphocytes, 27% monocytes, 9% eosinophils, 4% neutrophils); protein level of 155 mg/dL; and glucose level of 45 mg/dL ([Figure 1](#F1){ref-type="fig"}). He was started on empiric vancomycin, ceftriaxone, and acyclovir.

![Cell counts and laboratory values in cerebrospinal fluid from a previously healthy adult with *Baylisascaris* meningoencephalitis, California, USA. Hospital day 4 was June 1, 2015; hospital day 54 was July 25, 2015. Samples for 7-month values were obtained on January 1, 2016.](15-1939-F1){#F1}

Over the next 3 days, the patient sustained precipitous cognitive and functional declines; incontinence, right-sided facial droop, dysarthria, diffuse hyperreflexia, and ataxia developed. Initial infectious disease diagnostics returned negative results ([Table 1](#T1){ref-type="table"}), so antimicrobial drugs were discontinued. CSF analysis on day 11 showed persistent pleocytosis and marked elevation of eosinophils to 34% ([Figure 1](#F1){ref-type="fig"}). CSF cytologic and flow cytometric testing showed no malignant cells but did show reactive lymphocytes and many eosinophils, consistent with chronic inflammation.

###### Microbiologic diagnostics obtained during testing of a previously healthy patient with *Baylisascaris* meningoencephalitis, California, USA\*

  Diagnostic study                                     Site            Result
  ---------------------------------------------------- --------------- ------------------------
  Bacterial cultures ×4                                Blood and CSF   Negative
  *Coxiella* antibody                                  Blood           Negative
  *Bartonella henselae* and *B. quintana* antibodies   Blood           Negative
  *Mycoplasma* antibody                                Blood           IgM negative, IgG 1:5
  Rickettsial antibody panel                           Blood           Negative
  Venereal Disease Research Laboratory test            CSF             Negative
  Lyme disease antibody                                CSF             Negative
  Cytomegalovirus PCR                                  CSF             Negative
  Epstein--Barr virus PCR                              CSF             Negative
  Enterovirus PCR                                      CSF             Negative
  Herpes simplex virus PCR                             CSF             Negative
  Lymphocytic choriomeningitis virus IgM, IgG          CSF             IgM 1:2, IgG negative†
  Varicella zoster virus PCR, IgM, IgG                 CSF             Negative
  West Nile virus IgM, IgG                             CSF             Negative
  *Baylisascaris* antibody                             Blood and CSF   Positive
  *Strongyloides* antibody                             Blood           Negative
  *Trichinella* antibody                               Blood           Negative
  *Toxocara* antibody                                  Blood           Negative
  *Toxoplasma* antibody                                Blood           Negative
  Ova and parasite stain                               CSF             Negative
  Fungal stains and cultures ×4                        Blood and CSF   Negative
  *Coccidiodes* antibody by complement fixation        Blood and CSF   Negative
  *Coccidiodes* antibody by immunodiffusion            Blood           Negative
  Cryptococcal antigen                                 Blood and CSF   Negative
  AFB stains and cultures ×4                           CSF             Negative
  Broad-range PCR (bacteria, fungi, AFB)               CSF             Negative
  Cytology                                             CSF             Chronic inflammation

\*AFB, acid-fast bacilli; CSF, cerebrospinal fluid.  †A low-titer IgM for lymphocytic choriomeningitis virus was considered to be a false-positive result.

A brain MRI on day 13 showed new nodular enhancement at the gray--white junction ([Figure 2](#F2){ref-type="fig"}, panels A--D) and patchy T2 signal abnormalities in the cerebellar, pontine, and supratentorial white matter. Due to progressive severe functional and cognitive decline, an unclear diagnosis, and concerning MRI abnormalities, the patient was transferred on day 15 to the University of California San Francisco Medical Center for evaluation. Upon transfer, he was lethargic and had moderate global aphasia and echolalia, a left forehead--sparing facial droop, spasticity in the arms, diffuse hyperreflexia, and mute plantar responses.

![Magnetic resonance imaging scans showing brain abnormalities in a previously healthy adult with *Baylisascaris* meningoencephalitis, California, USA. A--D) Postgadolinium contrast T1 images obtained 4 weeks after symptom onset. A--C) Axial images, moving inferiorly to superiorly, demonstrating nodular bilateral enhancement within the cerebellar hemispheres, thalami, and subcortical white matter. D) Sagittal image further demonstrates multifocal areas of enhancement in cerebral hemispheres. Additional, mild T2 abnormalities (not shown) were present at the same time. E--H) T2/FLAIR (fluid attenuation inversion recovery) images obtained 6 weeks after symptom onset. E--G) Axial images, moving inferiorly to superiorly, demonstrating patchy and confluent hyperintense lesions throughout the supratentorial white matter and cerebellum. H) Sagittal image further demonstrates the high degree of white matter abnormality, which was not present on the earlier imaging. Postcontrast enhancement on T1 imaging (not shown) had nearly resolved at this time.](15-1939-F2){#F2}

Additional history from his family revealed that the patient had worked as a contractor for \>40 years in northern California. Several weeks before symptom onset, he had completed a project under his house, where raccoons and a skunk had been observed, and he had spent significant time working in a rural area with suspected raccoon activity. His occupation necessitated routine contact with soil, dust, and yard debris, and his wife said he regularly ate lunch at job sites without washing his hands. The patient was an avid hunter and had consumed bear meat 3 months before symptom onset.

Based on the patient's exposure history, we considered infection with *Baylisascaris*, *Toxocara*, *Trichinella*, *Coccidioides*, or other microbial pathogens ([Table 1](#T1){ref-type="table"}). Because of the patient's rapid neurologic decline, we initiated albendazole (20 mg/kg/d, given in doses every 12 h) and dexamethasone (4 mg every 6 h) on day 17 for empiric treatment of baylisascariasis or other helminth infection; we also initiated empiric fluconazole and doxycycline. His neurologic symptoms stabilized 1 week later.

On day 17, serum and CSF samples were sent to the Centers for Disease Control and Prevention (Atlanta, GA, USA) for *Baylisascaris procyonis* immunoassay testing. This test uses a recombinant BpRAG1 antigen and has a sensitivity of 88% and specificity of 98% ([@R5]). Thirteen days later, the results showed *B. procyonis* antibodies in the serum and CSF samples; results for all other studies were negative ([Table 1](#T1){ref-type="table"}). Repeat brain MRI on day 29 showed progression of white matter hyperintensity, near complete resolution of enhancement, and mild atrophy ([Figure 2](#F2){ref-type="fig"}, panels E--H). The patient began to show slow, but tangible, improvement in neurologic function after 4 weeks on albendazole and dexamethasone. This combination was continued for 6 weeks, after which albendazole was stopped and a 12-week dexamethasone taper was initiated. By 3 months, the patient had recovered orientation to person and place and limited motor coordination. After 7 months, he could walk with assistance, engage in simple conversations, and perform basic activities of daily living. At that time, CSF showed normalized cell counts ([Figure 1](#F1){ref-type="fig"}).

Most *B. procyonis* roundworm infections occur in young children because their frequency of oral exploration predisposes children to ingestion of infective eggs ([@R1]--[@R6]). However, *B. procyonis* infections have been reported in 3 adults and 2 teenagers ([@R7]--[@R11]). Of note, those 5 patients had preexisting neuropsychiatric conditions that predisposed them to ingestion of infective eggs via geophagic pica ([Table 2](#T2){ref-type="table"}) ([@R7]--[@R11]). In the case we report, the patient had no predisposing condition, but he probably had occupational exposure, potentiated by insufficient hand hygiene, to raccoon feces.

###### Cases of cerebrospinal fluid infection with *Baylisascaris* spp. roundworms in adults and adolescents, United States and Canada, 1986--2015

  Year   Patient age, y   Location                   Risk factor(s)                                                         Treatment                                              Outcome                          Reference
  ------ ---------------- -------------------------- ---------------------------------------------------------------------- ------------------------------------------------------ -------------------------------- -------------
  1986   21               Oregon, USA                Developmental delay and geophagia                                      Not recorded                                           Persistent residual deficits     ([@R7])
  2000   17               California, USA            Developmental delay and geophagia                                      Albendazole and antiinflammatory drugs                 Died                             ([@R8])
  2007   17               Oregon, USA                Altered mentation from drug abuse                                      None                                                   Aphasia and memory deficits      ([@R9])
  2009   54               Missouri, USA              Intellectual disability; eating food scraps from public garbage cans   None                                                   Died                             ([@R10])
  2012   73               British Columbia, Canada   Dementia                                                               None                                                   Identified at time of autopsy    ([@R11])
  2015   63               California, USA            Home or occupational exposure                                          Albendazole (20 mg/kg/d) + dexamethasone (1 mg/kg/d)   Partial recovery after 6 weeks   This report

Most symptomatic cases of neural larva migrans caused by infection with *Baylisascaris* roundworms have resulted in irreversible neurologic damage, and 5 deaths have been reported ([@R1]--[@R3]). Partial to complete recovery occurred in 4 cases, presumably due to a low level of infection at the time of diagnosis, early aggressive treatment, or both ([@R9],[@R12]--[@R14]).

Because the differential diagnosis for eosinophilic meningitis is relatively restricted, we principally considered infectious etiologies consistent with the patient's demographics and exposure history. His risk factors associated with an infectious etiology included living and working near a region where *Coccidiodes immitis* is endemic and exposure to raccoon-associated *Baylisascaris* roundworms. For this patient, MRI findings similar to those for other *B. procyonis*--infected patients included subcortical nodular enhancement and linear hyperintensities in the cerebellar white matter on T1- and T2-weighted images ([Figure 2](#F2){ref-type="fig"}) ([@R14]).

The optimal treatment for baylisascariasis in adults is not known; the current recommendation for albendazole (25--50 mg/kg/d) comes from successful empiric regimens used in children (<http://www.cdc.gov/parasites/baylisascaris/health_professionals/index.html#tx>). Albendazole is the cornerstone of therapy for *B. procyonis* neural larva migrans and is combined with a corticosteroid to enhance central nervous system (CNS) penetration and mitigate inflammation-associated tissue necrosis ([@R3],[@R4],[@R15]). Due to low CNS penetration, ivermectin is ineffective for treating *B. procyonis* neural larva migrans ([@R1],[@R3]). Despite treatment, outcomes are often poor because extensive CNS inflammatory damage and tissue necrosis usually occurs before diagnosis ([@R3]*,*[@R4]*,*[@R6]); thus, early recognition of baylisascariasis and prompt initiation of treatment are essential. Because of concern for adverse side effects, including agranulocytosis and hepatotoxicity, we used a 6-week regimen of albendazole plus dexamethasone. We observed reversal of disease progression and a modest neurocognitive recovery after 3 months.

Conclusions
===========

This case demonstrates that severe neurologic disease from infection with *B. procyonis* roundworms can develop in otherwise healthy adults with incidental exposures. The patient in this report had no history of overt immune compromise and few concurrent conditions and was generally well until the inadvertent ingestion of occult *B. procyonis* eggs. This case highlights the importance of considering baylisascariasis in all patients with eosinophilic meningitis, and it underscores the importance of obtaining a detailed exposure history, understanding the causes of eosinophilic meningitis, and initiating early aggressive therapy when infection is suspected.
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